Literature DB >> 25488285

The importance of an ophthalmologic examination in patients with juvenile idiopathic arthritis.

Alejandro Rodríguez-García1.   

Abstract

Uveitis occurs within the first year of arthritis onset in 73% of patients with juvenile idiopathic arthritis (JIA) considered at risk. The intraocular inflammation is characterized by an insidious onset and a silent and chronic clinical course capable of producing significant visual loss due to complications such as: cataract formation, secondary glaucoma, maculopathy and optic neuropathy. The absence of initial signs and symptoms, along with a deficient ophthalmic monitoring produce a delay in diagnosis with serious consequences. It has been estimated that 47% of JIA patients at risk for developing uveitis are legally blind (20/200 or worse) at least in one eye at the time of their first visit to the ophthalmologist. To reduce ocular complications and improve their visual outcome, it is necessary that rheumatologists refer all patients recently diagnosed (within the first month) with JIA for an ophthalmic evaluation, and maintain periodical follow-up visits based on classification and risk category of the disease.
Copyright © 2014 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Artritis idiopática juvenil; Blindness; Cataract; Catarata; Ceguera; Glaucoma; Juvenile idiopathic arthritis; Uveitis; Uveítis

Mesh:

Year:  2014        PMID: 25488285     DOI: 10.1016/j.reuma.2014.08.003

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  2 in total

1.  Outcome of Juvenile Idiopathic Arthritis Associated Uveitis in Two Disease Subtypes.

Authors:  Dragana Lazarević; Ivana Nikolić; Marija Ratković-Janković; Jelena Vojinović
Journal:  Arch Rheumatol       Date:  2017-01-06       Impact factor: 1.472

2.  Comparison of uveitis in the course of juvenile idiopathic arthritis with isolated uveitis in children - own experiences.

Authors:  Agnieszka Zygmunt; Joanna Lipińska; Małgorzata Biernacka-Zielińska; Ewa Lipiec; Anna Niwald; Elżbieta Smolewska
Journal:  Reumatologia       Date:  2018-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.